About us
Overview
Our strategy
Our leadership
How we’re funded
Our history
What we do
Overview
Our science
Therapeutics
Diagnostics development
Partnering with us
Funding, projects and partnerships
Available technologies
LifeArc Ventures
IP management and tech transfer
Policy and public affairs
Translational Challenges
Overview
Motor Neuron Disease
Chronic Respiratory Infection
Global Health
Antimicrobial Resistance
Neglected Tropical Diseases
Emerging Viral Threats
Rare Disease
Childhood Cancer
News and events
News
Events
Careers
Overview
Benefits and rewards
Early careers
Current vacancies
Contact us
Search
Toggle Menu
Search
Search
Search
Refine results
Content Type
Careers
Case Studies
Funding Calls
Other Technologies
Pages
People
Posts
Projects
Publications
Therapeutics
Topic
Company updates
Motor neuron disease
Chronic respiratory infection
Global health
Rare disease
Childhood cancer
Neurodegeneration
Policy and public affairs
Technology transfer
Our science
Ventures
LifeArc licenses lead stage molecules to Daiichi Sankyo
Post
16 April 2019
Read more
: LifeArc licenses lead stage molecules to Daiichi Sankyo
LifeArc Ventures launches new brand with dedicated website, LinkedIn and Twitter
Post
23 March 2023
Read more
: LifeArc Ventures launches new brand with dedicated website, LinkedIn and Twitter
Meet our industrial placement students – class of 2023
Post
11 May 2023
Read more
: Meet our industrial placement students – class of 2023
The MND Insights Group and community surveys
Project
23 March 2024
Read more
: The MND Insights Group and community surveys
The art of turning ideas into products
Post
14 March 2011
Read more
: The art of turning ideas into products
LifeArc and Future Fund provide £3.0m in funding to Avvinity Therapeutics
Post
23 September 2020
Read more
: LifeArc and Future Fund provide £3.0m in funding to Avvinity Therapeutics
LifeArc supports MRC spin-out to Series A funding
Case Study
15 December 2020
Read more
: LifeArc supports MRC spin-out to Series A funding
Opportunity Assessment Group (OAG) Internship – 3 months
Careers
23 September 2024
Read more
: Opportunity Assessment Group (OAG) Internship – 3 months
Partnership with Metrion Biosciences to support LifeArc’s neuroscience small molecule drug discovery programme
Post
31 July 2017
Read more
: Partnership with Metrion Biosciences to support LifeArc’s neuroscience small molecule drug discovery programme
Tumour analysis following surgery could provide breakthrough in predicting how well cancer patients respond to drug treatment
Post
8 November 2017
Read more
: Tumour analysis following surgery could provide breakthrough in predicting how well cancer patients respond to drug treatment
New £30m initiative to address global threat by accelerating the pace of antimicrobial innovation
Post
19 October 2023
Read more
: New £30m initiative to address global threat by accelerating the pace of antimicrobial innovation
The Aisling Burnand Daphne Jackson Research Fellowship, sponsored by LifeArc
Post
1 March 2023
Read more
: The Aisling Burnand Daphne Jackson Research Fellowship, sponsored by LifeArc
Previous Page
1
2
3
4
5
…
10
Next Page
Close Modal
WordPress development by
Andy White
using
PorterWP